Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9650
+0.0550 (2.88%)
NASDAQ · Last Trade: May 4th, 11:45 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors